CG
WST icon

Cutler Group’s West Pharmaceutical WST Stock Holding History

Cutler Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,000
Closed -$5K – 3796
2023
Q4 		$5K Buy
+5,000
New +$1.77M ﹤0.01% 2779
2016
Q4 		– Sell
-9,600
Closed -$15K – 7441
2016
Q3 		$15K Buy
9,600
+9,200
+2,300% +$730K ﹤0.01% 3746
2016
Q2 		$2K Sell
400
-17,900
-98% -$1.3M ﹤0.01% 5787
2016
Q1 		$28K Buy
18,300
+17,700
+2,950% +$1.06M ﹤0.01% 2938
2015
Q4 		$1K Buy
+600
New +$36.1K ﹤0.01% 6128

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Cutler Group's WST Position: Q4 2017 in Review

Cutler Group sold out of West Pharmaceutical (WST) in Q4 2017, closing a stake of 68 shares — an estimated $6K sold.

Cutler Group first reported a position in WST in Q4 2015 and held it in 6 quarters. The position peaked at $241K in Q2 2017. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

  • Cutler Group reported no remaining West Pharmaceutical position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 68 West Pharmaceutical shares in Q4 2017, an estimated $6K.
  • Cutler Group first reported a position in West Pharmaceutical in Q4 2015 and held it in 6 quarters.
  • Cutler Group's West Pharmaceutical position peaked at $241K in Q2 2017.
  • 338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.